Literature DB >> 18562694

Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1.

Alexandra Klein1, Daniela Flügel, Thomas Kietzmann.   

Abstract

The serine/threonine kinase-15 (STK15) acts as a cell cycle regulator being overexpressed in various tumors. One mechanism that could contribute to overexpression of STK15 is tumor hypoxia where hypoxia-inducible factor-1 (HIF-1) is a major regulator of transcription. Therefore, we analyzed whether hypoxia and HIF-1 could contribute to overexpression of STK15. We found that hypoxia increased STK15 expression and STK15 promoter activity in HepG2 tumor cells. Overexpression of HIF-1 alpha induced STK15 gene transcription, whereas HIF-1 alpha siRNA and overexpression of prolyl hydroxylase 2 (PHD-2), a negative regulator of HIF-1 alpha, reversed this effect. In addition, site-directed mutagenesis experiments and chromatin immunoprecipitation revealed that from the three putative hypoxia responsive elements (HRE) within the STK15 promoter only HRE-2 was functional and bound HIF-1. Further, siRNA against STK15 inhibited proliferation of HepG2 cells induced by hypoxia. These results show that STK15 gene transcription can be regulated by hypoxia and HIF-1 via HRE-2 of the STK15 promoter. Thus, tumor hypoxia may trigger overexpression of STK15 observed in various tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562694      PMCID: PMC2526712          DOI: 10.1091/mbc.e08-01-0042

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  64 in total

1.  Perivenous expression of the mRNA of the three hypoxia-inducible factor alpha-subunits, HIF1alpha, HIF2alpha and HIF3alpha, in rat liver.

Authors:  T Kietzmann; Y Cornesse; K Brechtel; S Modaressi; K Jungermann
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

2.  Pattern of chromosomal imbalances in non-B virus related hepatocellular carcinoma detected by comparative genomic hybridization.

Authors:  M A Collonge-Rame; S Bresson-Hadni; S Koch; J P Carbillet; O Blagosklonova; G Mantion; J P Miguet; B Heyd; J L Bresson
Journal:  Cancer Genet Cytogenet       Date:  2001-05

3.  Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes.

Authors:  T Kietzmann; U Roth; K Jungermann
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers.

Authors:  Y Miyoshi; K Iwao; C Egawa; S Noguchi
Journal:  Int J Cancer       Date:  2001-05-01       Impact factor: 7.396

7.  Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.

Authors:  K Tanimoto; Y Makino; T Pereira; L Poellinger
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

8.  Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element/activator protein-1 element in primary cultures of rat hepatocytes.

Authors:  S Immenschuh; V Hinke; A Ohlmann; S Gifhorn-Katz; N Katz; K Jungermann; T Kietzmann
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

9.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.

Authors:  H Zhou; J Kuang; L Zhong; W L Kuo; J W Gray; A Sahin; B R Brinkley; S Sen
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

10.  Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation.

Authors:  C Sakakura; A Hagiwara; R Yasuoka; Y Fujita; M Nakanishi; K Masuda; K Shimomura; Y Nakamura; J Inazawa; T Abe; H Yamagishi
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

View more
  24 in total

Review 1.  Tumor hypoxia and genetic alterations in sporadic cancers.

Authors:  Minoru Koi; Clement R Boland
Journal:  J Obstet Gynaecol Res       Date:  2011-01-27       Impact factor: 1.730

2.  Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.

Authors:  Norman L Lehman; James P O'Donnell; Lisa J Whiteley; Robert T Stapp; Trang D Lehman; Kathleen M Roszka; Lonni R Schultz; Caitlin J Williams; Tom Mikkelsen; Stephen L Brown; Jeffrey A Ecsedy; Laila M Poisson
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

Review 3.  Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

4.  RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma.

Authors:  Sumanta K Pal; Miaoling He; Tommy Tong; Huiqing Wu; Xueli Liu; Clayton Lau; Jin-Hui Wang; Charles Warden; Xiwei Wu; Sabina Signoretti; Toni K Choueiri; Jose A Karam; Jeremy O Jones
Journal:  Mol Cancer Res       Date:  2014-09-02       Impact factor: 5.852

5.  VHL inactivation induces HEF1 and Aurora kinase A.

Authors:  Jianyong Xu; Huapeng Li; Bo Wang; Yan Xu; Jiayin Yang; Xiaofei Zhang; Sarah K Harten; Deepa Shukla; Patrick H Maxwell; Duanqing Pei; Miguel A Esteban
Journal:  J Am Soc Nephrol       Date:  2010-09-23       Impact factor: 10.121

6.  Transcription factor HIF1A: downstream targets, associated pathways, polymorphic hypoxia response element (HRE) sites, and initiative for standardization of reporting in scientific literature.

Authors:  Lucija Slemc; Tanja Kunej
Journal:  Tumour Biol       Date:  2016-09-19

7.  Targeting aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis.

Authors:  Carmelle V Romain; Pritha Paul; Sora Lee; Jingbo Qiao; Dai H Chung
Journal:  Anticancer Res       Date:  2014-05       Impact factor: 2.480

8.  The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1.

Authors:  Isabel Diebold; Andreas Petry; John Hess; Agnes Görlach
Journal:  Mol Biol Cell       Date:  2010-04-28       Impact factor: 4.138

9.  β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma.

Authors:  Ruhee Dere; Ashley Lyn Perkins; Tasneem Bawa-Khalfe; Darius Jonasch; Cheryl Lyn Walker
Journal:  J Am Soc Nephrol       Date:  2014-10-13       Impact factor: 10.121

10.  The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.

Authors:  Shi-Yun Cui; Jia-Yuan Huang; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Wei De; Rui Wang; Long-Bang Chen
Journal:  Cell Cycle       Date:  2013-08-07       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.